JP2012503674A5 - - Google Patents

Download PDF

Info

Publication number
JP2012503674A5
JP2012503674A5 JP2011529275A JP2011529275A JP2012503674A5 JP 2012503674 A5 JP2012503674 A5 JP 2012503674A5 JP 2011529275 A JP2011529275 A JP 2011529275A JP 2011529275 A JP2011529275 A JP 2011529275A JP 2012503674 A5 JP2012503674 A5 JP 2012503674A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
pacap
composition according
compound
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011529275A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012503674A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/058445 external-priority patent/WO2010036936A2/en
Publication of JP2012503674A publication Critical patent/JP2012503674A/ja
Publication of JP2012503674A5 publication Critical patent/JP2012503674A5/ja
Pending legal-status Critical Current

Links

JP2011529275A 2008-09-25 2009-09-25 抗癌剤との補助的治療薬としての下垂体アデニル酸シクラーゼ活性化ポリペプチド（ｐａｃａｐ）及びｐａｃａｐ類似体の使用 Pending JP2012503674A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19416608P 2008-09-25 2008-09-25
US61/194,166 2008-09-25
PCT/US2009/058445 WO2010036936A2 (en) 2008-09-25 2009-09-25 Use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with anticancer agents

Publications (2)

Publication Number Publication Date
JP2012503674A JP2012503674A (ja) 2012-02-09
JP2012503674A5 true JP2012503674A5 (https=) 2013-11-28

Family

ID=42060409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011529275A Pending JP2012503674A (ja) 2008-09-25 2009-09-25 抗癌剤との補助的治療薬としての下垂体アデニル酸シクラーゼ活性化ポリペプチド（ｐａｃａｐ）及びｐａｃａｐ類似体の使用

Country Status (7)

Country Link
US (1) US20110268789A1 (https=)
EP (1) EP2337577A4 (https=)
JP (1) JP2012503674A (https=)
CN (1) CN102215859B (https=)
AU (1) AU2009296456B2 (https=)
CA (1) CA2738549A1 (https=)
WO (1) WO2010036936A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2779496A1 (en) 2009-11-02 2011-05-05 The Administrators Of The Tulane Educational Fund Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use
EP2533795A4 (en) * 2010-02-05 2013-10-16 Univ Tulane USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGUE AS SUPPORTING TREATMENT WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF MTOR COMPLEXES
WO2013074966A1 (en) * 2011-11-17 2013-05-23 The Administrators Of The Tulane Educational Fund Use of pituitary adenylate cyclase activating polypeptide (pacap) and pacap analogs for treating contrast -indused nephropathy
CN103145851B (zh) * 2013-02-22 2014-07-02 暨南大学 重组蛋白PACAP38-NtA及其编码基因与应用
EP3565573B1 (en) 2017-01-05 2023-08-23 The Regents of The University of California Pac1 receptor agonists (maxcaps) and uses thereof
ES2677242B1 (es) * 2017-01-31 2019-03-27 Univ Alcala Henares Nanoconjugados formados por moléculas dendríticas y péptidos como agentes antitumorales frente al cáncer
EP3712164A4 (en) * 2017-11-14 2021-08-18 Senju Pharmaceutical Co., Ltd. PEPTIDE STABILIZED BY PACAP
US20220202905A1 (en) * 2019-05-14 2022-06-30 Senju Pharmaceutical Co., Ltd. Composition for preventing or treating neurotrophic keratitis which contains pacap peptide or stabilized pacap peptide
DE102024001175A1 (de) * 2024-04-04 2025-10-09 ReViSan Healthcare GmbH Zubereitung zur Behandlung von entzündlichen Erkrankungen der Atemwege.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003228050A1 (en) * 2002-05-03 2003-11-17 Neuronova Ab Therapeutic use of PACAP, Maxadilan, PACAP receptor agonist and/or ADCYAP1R1 in the treatment of CNS disorders
ES2523659T3 (es) * 2004-06-11 2014-11-28 Vectus Biosystems Limited Composiciones y procedimientos para el tratamiento de enfermedades cardiovasculares
WO2006012394A1 (en) * 2004-07-21 2006-02-02 Tulane University Health Sciences Center Treatment of renal dysfunction and multiple myeloma using pacap compounds
EP2190533A2 (en) * 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Use of a peptide as a therapeutic agent

Similar Documents

Publication Publication Date Title
JP2012503674A5 (https=)
CN104717966B (zh) 用于癌症靶向治疗和预防癌症复发的含有基于血红蛋白的氧载体的药物组合物
JP2021505661A5 (https=)
JP2010515748A5 (https=)
WO2016160621A2 (en) Nk-92 cells in combination therapy with cancer drugs
SG171823A1 (en) A nonapeptide with anti-tumour activity
CN112135639B (zh) 细胞组装介导的癌症免疫治疗检查点抑制剂的递送
EP4196133A2 (en) Methods and compositions for stimulating gamma delta t cells
JP2010535811A5 (https=)
JP2010524968A5 (https=)
JP2018532748A5 (https=)
TWI329646B (en) O, o'-amidomalonate and n, o-amidomalonate platinum complexes
CZ299686B6 (cs) Lécivo pro lécbu nádoru obsahující distamycinové deriváty
JP2018530525A5 (https=)
TWI454280B (zh) Pharmaceutical composition or combination
US20230173083A1 (en) Albumin-binding prodrug for preventing or treating cancer and pharmaceutical composition including the same
RU2471496C1 (ru) Средства, повышающие противоопухолевую и антиметастатическую активность цитостатических препаратов
US20110300234A1 (en) Methods of Treating Tumor Cells Using RHCC Protein, Fragment or Variant
Nosko et al. Biodistribution analysis of cisplatin in liposomal form in animals with cisplatin-resistant and cisplatin-sensitive carcinoma
JP2020063191A (ja) 薬物送達用担体及び薬物送達システム
US20230355568A1 (en) Therapeutic agent for malignant mesothelioma and method for selecting patient having malignant mesothelioma
TWI311053B (en) Antitumor therapy comprising distamycin derivatives
EP4727596A2 (en) Antibody-drug conjugates and linkers and methods of use thereof
KR20230092466A (ko) Pd-l1 저해가 가능한 전구약물을 포함하는 약학 조성물
WO2015123818A1 (en) Chemokine receptor antagonist and its combinational therapy